Competition for Neurocrine as Gocovri picks up new Parkinson’s indicationAdamas Pharmaceuticals’ Parkinson’s drug Gocovri has a new indication as an adjunctive treatment for levodopa/carbodopa in patients with Share XCompetition for Neurocrine as Gocovri picks up new Parkinson’s indicationhttps://pharmaphorum.com/news/competition-for-neurocrine-as-gocovri-picks-up-new-parkinsons-indication/
